We'll announce the price in a few months, it'll be approx Rs 200-400. We will finalise after manufacturing and discussion with Govt of India: Adar Poonawalla, CEO, Serum Institute of India on country's first Quadrivalent Human Papillomavirus Vaccine (qHPV) against Cervical Cancer pic.twitter.com/XG22MwsHK7
— ANI (@ANI) September 1, 2022